Islatravir safety analysis through week 96 from a Phase 2 trial in treatment naive adults with HIV-1 infection by Cunningham, D, Molina, J-M, Yazdanpanah, Y, Saud, AA, Anania, CC, Klopfer, SO, Grandhi, A, Eves, K, Hepler, D, Hwang, C, Lahoulou, R, Correll, TA

Get full text